1. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). (26th August 2022) Authors: Lyon, Alexander R; López-Fernández, Teresa; Couch, Liam S; Asteggiano, Riccardo; Aznar, Marianne C; Bergler-Klein, Jutta; Boriani, Giuseppe; Cardinale, Daniela; Cordoba, Raul; Cosyns, Bernard; Cutter, David J; de Azambuja, Evandro; de Boer, Rudolf A; Dent, Susan F; Farmakis, Dimitrios; Gevaert, S... Journal: European heart journal Issue: Volume 43:Number 41(2022) Page Start: 4229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemia. Issue 13 (10th November 2021) Authors: Sweet, Kendra; Bhatnagar, Bhavana; Döhner, Hartmut; Donnellan, Will; Frankfurt, Olga; Heuser, Michael; Kota, Vamsi; Liu, Hongtao; Raffoux, Emmanuel; Roboz, Gail J.; Röllig, Christoph; Showel, Margaret M.; Strickland, Stephen A.; Vives, Susana; Tang, Shijie; Unger, Thaddeus J.; Joshi, Anita; Shen,... Journal: Leukemia & lymphoma Issue: Volume 62:Issue 13(2021) Page Start: 3192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A new player in IDH1 mutated myeloid neoplasias. Issue 1 (January 2023) Authors: Heuser, Michael Journal: Lancet Issue: Volume 10:Issue 1(2023) Page Start: e7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations. (29th March 2015) Authors: Fiedler, Walter; Kayser, Sabine; Kebenko, Maxim; Janning, Melanie; Krauter, Jürgen; Schittenhelm, Marcus; Götze, Katharina; Weber, Daniela; Göhring, Gudrun; Teleanu, Veronica; Thol, Felicitas; Heuser, Michael; Döhner, Konstanze; Ganser, Arnold; Döhner, Hartmut; Schlenk, Richard F. Journal: British journal of haematology Issue: Volume 169:Number 5(2015:Jun.) Page Start: 694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia. (9th June 2020) Authors: Fiedler, Walter; Chromik, Joerg; Amberg, Stefanie; Kebenko, Maxim; Thol, Felicitas; Schlipfenbacher, Vera; Christine Wilke, Anne; Modemann, Franziska; Janning, Melanie; Serve, Hubert; Ganser, Arnold; Bokemeyer, Carsten; Theile, Susann; Deppermann, Ute; Kranich, Anne L.; Heuser, Michael Journal: British journal of haematology Issue: Volume 190:Number 3(2020) Page Start: e169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation. (16th September 2019) Authors: Mannina, Daniele; Gagelmann, Nico; Badbaran, Anita; Ditschkowski, Markus; Bogdanov, Rashit; Robin, Marie; Cassinat, Bruno; Heuser, Michael; Shahswar, Rabia; Thol, Felicitas; Beelen, Dietrich; Kröger, Nicolaus Journal: European journal of haematology Issue: Volume 103:Number 6(2019) Page Start: 552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. An optimized lentiviral vector system for conditional RNAi and efficient cloning of microRNA embedded short hairpin RNA libraries. (September 2017) Authors: Adams, Felix F.; Heckl, Dirk; Hoffmann, Thomas; Talbot, Steven R.; Kloos, Arnold; Thol, Felicitas; Heuser, Michael; Zuber, Johannes; Schambach, Axel; Schwarzer, Adrian Journal: Biomaterials Issue: Volume 139(2017) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients. (13th October 2017) Authors: Kayser, Sabine; Feszler, Maximilian; Krzykalla, Julia; Schick, Matthias; Kramer, Michael; Benner, Axel; Thol, Felicitas; Platzbecker, Uwe; Müller‐Tidow, Carsten; Ho, Anthony D.; Ehninger, Gerhard; Heuser, Michael; Schlenk, Richard F.; Thiede, Christian; Röllig, Christoph; Krämer, Alwin Journal: European journal of haematology Issue: Volume 99:Number 6(2017) Page Start: 544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Emerging strategies to target the dysfunctional cohesin complex in cancer. (3rd June 2019) Authors: Mintzas, Konstantinos; Heuser, Michael Journal: Expert opinion on therapeutic targets Issue: Volume 23:Number 6(2019:Jun.) Page Start: 525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Epigenetics in myelodysplastic syndromes. (August 2018) Authors: Heuser, Michael; Yun, Haiyang; Thol, Felicitas Journal: Seminars in cancer biology Issue: Volume 51(2018) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗